Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Padraig Warde

Showing results (121-130 of 174) with videos related to

Pageof 18
Sort By:
Brachytherapy|December 22, 2022
Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancerNoelia Sanmamed, Lisa Joseph, Juanita Crook, et al.
BMC Cancer|January 5, 2019
A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapyShabbir M H Alibhai, Daniel Santa Mina, Paul Ritvo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2019
Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on SurveillanceRobert J Hamilton, Madhur Nayan, Lynn Anson-Cartwright, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Pathological predictors for site of local recurrence after radiotherapy for prostate cancerSupriya Chopra, Ants Toi, Nathan Taback, et al.
BJU International|July 5, 2024
Primary retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumours: outcomes and adjuvant chemotherapyAhmad Mousa, Lynn Anson-Cartwright, Eshetu G Atenafu, et al.
European Urology Oncology|July 7, 2019
Detection of Relapse by Low-dose Computed Tomography During Surveillance in Stage I Testicular Germ Cell TumoursPeter Chung, Martin E O'Malley, Michael A S Jewett, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2004
Late toxicity following conventional radiotherapy for prostate cancer: analysis of the EORTC trial 22863Fatma Ataman, Alfredo Zurlo, Xavier Artignan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 24, 2014
The prostate cancer risk stratification project: database construction and risk stratification outcome analysisGeorge Rodrigues, Himu Lukka, Padraig Warde, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 9, 2014
Predictors of breast radiotherapy plan modifications: quality assurance rounds in a large cancer centreTimothy Lymberiou, Susanne Galuszka, Grace Lee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2013
The prostate cancer risk stratification (ProCaRS) project: recursive partitioning risk stratification analysisGeorge Rodrigues, Himu Lukka, Padraig Warde, et al.
Pageof 18

Showing results (121-130 of 174) with videos related to

Sort By:
Pageof 18
Brachytherapy|December 22, 2022
Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancerNoelia Sanmamed, Lisa Joseph, Juanita Crook, et al.
BMC Cancer|January 5, 2019
A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapyShabbir M H Alibhai, Daniel Santa Mina, Paul Ritvo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2019
Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on SurveillanceRobert J Hamilton, Madhur Nayan, Lynn Anson-Cartwright, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Pathological predictors for site of local recurrence after radiotherapy for prostate cancerSupriya Chopra, Ants Toi, Nathan Taback, et al.
BJU International|July 5, 2024
Primary retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumours: outcomes and adjuvant chemotherapyAhmad Mousa, Lynn Anson-Cartwright, Eshetu G Atenafu, et al.
European Urology Oncology|July 7, 2019
Detection of Relapse by Low-dose Computed Tomography During Surveillance in Stage I Testicular Germ Cell TumoursPeter Chung, Martin E O'Malley, Michael A S Jewett, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2004
Late toxicity following conventional radiotherapy for prostate cancer: analysis of the EORTC trial 22863Fatma Ataman, Alfredo Zurlo, Xavier Artignan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 24, 2014
The prostate cancer risk stratification project: database construction and risk stratification outcome analysisGeorge Rodrigues, Himu Lukka, Padraig Warde, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 9, 2014
Predictors of breast radiotherapy plan modifications: quality assurance rounds in a large cancer centreTimothy Lymberiou, Susanne Galuszka, Grace Lee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2013
The prostate cancer risk stratification (ProCaRS) project: recursive partitioning risk stratification analysisGeorge Rodrigues, Himu Lukka, Padraig Warde, et al.
Pageof 18